Denmark's Genmab said adding its bispecific antibody petosemtamab to MSD's Keytruda (pembrolizumab) cut the risk of death by ...
From Berlin biotech NOXXON through a strategic realignment and considerations of cryptocurrency investments, and now back to ...
Swiss DARPin specialist Molecular Partners is shifting its entire focus to radiopharmaceuticals and plans to cut up to 55 ...
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results